Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH): -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (28)	2/14/2002 11:04:58 PM
From: tuck	Read Replies (1) \| Respond to of 510

So CIPH actually beat estimates by a couple of pennies. I'm not quite sure what CIPH means by "process proteomics." None of this is covered in filings or on their web page; the BioSepra munch was fairly recent (and BioSepra's page is no help). Process chromatography involves separating complex mixtures to get the part you want in large amounts (as opposed to a little bit needed for an experiment, maybe not knowing in advance exactly what the bit is). How this would be done with protein chips is eluding me. Small chips and production quantities seem mutually exclusive to me. Quality control (normally done with raman spectrometers, I believe)? Yet they already have a customer? Sheesh, yet another conference call to listen to. Hope somebody asks this question. Cheers, Tuck